Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Chris Lange | Jul 13, 2015 at 7:55 AM EDT

Short Sellers Back Off Big Biotech

24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.

Jon C. Ogg | Jul 10, 2015 at 12:35 PM EDT

Biogen Loses Its Head of Research and Development

Biogen announced on Friday that it is losing its head of research and development at the end of July.

Chris Lange | Jun 25, 2015 at 7:50 AM EDT

Short Sellers Get More Selective on Big Biotech

The short interest data are out for the June 15 settlement date, and overall, short interest in the selected biotech…

Chris Lange | Jun 10, 2015 at 7:55 AM EDT

Short Sellers Lose Some Conviction Against Big Biotech

The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech…

Chris Lange | May 28, 2015 at 8:25 AM EDT

Short Sellers Get Even More Ambitious Against Biotech Leaders

The short interest data are out for the May 15 settlement date. Biotech companies are considered a riskier group of…

Chris Lange | May 12, 2015 at 8:05 AM EDT

Short Sellers Start to Get Nervous on Biotech

The short interest data are out for the April 30 settlement date, and for most of the selected biotech stocks,…

Lee Jackson | May 6, 2015 at 9:15 AM EDT

Credit Suisse Adds New Stocks to Buy to Top Picks List

The higher the market goes, the harder it is for investors to know what to do. One good strategy is…

Chris Lange | Apr 27, 2015 at 8:30 AM EDT

Short Sellers Become More Wary of Big Biotech

The short interest data are out for the April 15 settlement date. 24/7 Wall St. has reviewed the top biotech…

Chris Lange | Apr 24, 2015 at 9:45 AM EDT

Will Biogen Earnings Interrupt the Biotech Bull Market?

Biogen reported disappointing first-quarter financials before the markets opened Friday.

Chris Lange | Apr 13, 2015 at 8:35 AM EDT

Short Sellers Increase Their Bets Against Biotech Stocks

The March 31 short interest data have been compared with the March 13 figures, and for most of the selected…

Lee Jackson | Mar 27, 2015 at 8:35 AM EDT

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

In a new report from RBC, while they think the selling and profit taking in biotechs could go on, they…

Jon C. Ogg | Mar 26, 2015 at 7:25 AM EDT

7 Companies That Seriously Should Split Their Stocks

While investors have been enjoying ever higher dividends and buybacks at a new record, you just do not see waves…

Chris Lange | Mar 25, 2015 at 9:15 AM EDT

Major Biotech Is So-So for Short Sellers

The March 13 short interest data in top biotechs have been compared with the end of February figures, and across…

Jon C. Ogg | Mar 23, 2015 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples, Tyco and More

Monday's top analyst upgrades and downgrades include AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples and Tyco International.

Chris Lange | Mar 20, 2015 at 9:50 AM EDT

Alzheimer’s Drug Could Be Instant Blockbuster for Biogen Idec

Friday morning, Biogen Idec announced positive results related to its Alzheimer's study. Any real Alzheimer's drug certainly would make the…

1 … 23 24 25 26 27 … 41

Biogen : BIIB

All Biogen Articles

Short Sellers Back Off Big Biotech

Biogen Loses Its Head of Research and Development

Short Sellers Get More Selective on Big Biotech

Short Sellers Lose Some Conviction Against Big Biotech

Short Sellers Get Even More Ambitious Against Biotech Leaders

Short Sellers Start to Get Nervous on Biotech

Credit Suisse Adds New Stocks to Buy to Top Picks List

Short Sellers Become More Wary of Big Biotech

Will Biogen Earnings Interrupt the Biotech Bull Market?

Short Sellers Increase Their Bets Against Biotech Stocks

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

7 Companies That Seriously Should Split Their Stocks

Major Biotech Is So-So for Short Sellers

Top Analyst Upgrades and Downgrades: AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples, Tyco and More

Alzheimer’s Drug Could Be Instant Blockbuster for Biogen Idec

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Biogen : BIIB

All Biogen Articles

Short Sellers Back Off Big Biotech

Biogen Loses Its Head of Research and Development

Short Sellers Get More Selective on Big Biotech

Short Sellers Lose Some Conviction Against Big Biotech

Short Sellers Get Even More Ambitious Against Biotech Leaders

Short Sellers Start to Get Nervous on Biotech

Credit Suisse Adds New Stocks to Buy to Top Picks List

Short Sellers Become More Wary of Big Biotech

Will Biogen Earnings Interrupt the Biotech Bull Market?

Short Sellers Increase Their Bets Against Biotech Stocks

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

7 Companies That Seriously Should Split Their Stocks

Major Biotech Is So-So for Short Sellers

Top Analyst Upgrades and Downgrades: AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples, Tyco and More

Alzheimer’s Drug Could Be Instant Blockbuster for Biogen Idec

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%